Angiogenesis , Metastasis , and the Cellular Microenvironment Fractalkine Receptor CX 3 CR 1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of the Chemokine CX3CL1 as a New Regulator of Malignant Cell Proliferation in Epithelial Ovarian Cancer

  2011cited by this paper
• The Origin of Ovarian Carcinomas: A Unifying Hypothesis

  2011cited by this paper
• Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.

  2011cited by this paper
• Eotaxin-3/CC Chemokine Ligand 26 Is a Functional Ligand for CX3CR1

  2010cited by this paper
• Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin

  2010cited by this paper
• Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth.

  2010cited by this paper
• Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma

  2010influential reference
• Involvement of M2‐polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Ovarian cancer development and metastasis.

  2010cited by this paper
• Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.

  2010cited by this paper
• In vitro metastatic colonization of human ovarian cancer cells to the omentum

  2010cited by this paper
• Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma

  2010cited by this paper
• GPCR signaling: understanding the pathway to successful drug discovery.

  2009cited by this paper
• Chemokine receptor antagonists: overcoming developmental hurdles

  2009cited by this paper
• Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling

  2009cited by this paper
• An engineered CX3CR1 antagonist endowed with anti‐inflammatory activity

  2009cited by this paper
• Management of recurrent ovarian carcinoma: current status and future directions.

  2009cited by this paper
• Phenotypic and functional delineation of murine CX(3)CR1 monocyte-derived cells in ovarian cancer.

  2009cited by this paper
• Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.

  2009cited by this paper
• Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma

  2008cited by this paper
• CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism.

  2008cited by this paper
• Chemokines and their receptors: drug targets in immunity and inflammation.

  2008cited by this paper
• L1 (CAM) (CD171) in ovarian serous neoplasms.

  2008cited by this paper
• Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion

  2008cited by this paper
• Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.

  2008cited by this paper
• Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

  2008cited by this paper
• Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

  2008cited by this paper
• New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

  2008cited by this paper
• Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

  2007cited by this paper
• Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

  2007cited by this paper
• Microenvironmental Regulation of Membrane Type 1 Matrix Metalloproteinase Activity in Ovarian Carcinoma Cells via Collagen-induced EGR1 Expression*

  2007cited by this paper
• Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.

  2006cited by this paper
• Malignant effusions are sources of fibronectin and other promigratory and proinvasive components

  2005cited by this paper
• Fractalkine in the peritoneal fluid of women with endometriosis

  2005cited by this paper
• Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.

  2005cited by this paper
• Management of recurrent epithelial ovarian carcinoma

  2005cited by this paper
• Viral Macrophage Inflammatory Protein-II and Fractalkine (CX3CL1) Chimeras Identify Molecular Determinants of Affinity, Efficacy, and Selectivity at CX3CR1

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Immune dysfunction in cancer patients.

  2002cited by this paper
• Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

  2002cited by this paper
• The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.

  2001cited by this paper
• Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

  2001cited by this paper
• CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins.

  2000cited by this paper
• Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.

  1999cited by this paper
• Chemokines and their role in tumor growth and metastasis.

  1998cited by this paper
• Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

  1998cited by this paper
• A new class of membrane-bound chemokine with a CX3C motif

  1997cited by this paper
• Role of fibronectin in diagnosis of malignant ascites.

  1997cited by this paper
• Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

  1997cited by this paper
• Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins.

  1996cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.

  1993cited by this paper
• Evasion of host defences by tumours

  1987cited by this paper
• Collagen production by human mesothelial cells in vitro

  1983influential reference

• No citing papers are available for this paper.